Stephen Crosswhite, BS

Prior to joining the UVM Center on Rural Addiction, Stephen was a research assistant at the Vermont Center on Behavioral and Health on Dr. Sigmon’s Interim Buprenorphine Treatment clinical trials, investigating technology-assisted medication delivery to reduce illicit opioid use and other risk behaviors. Stephen worked as a lab technician for a developmental neuroscience lab in the Department of Brain & Cognitive Sciences at the University of Rochester, and also led a team of sterile compounding technicians in USP797 High Risk and USP800 Hazardous Drug Compounding cleanrooms for four years.

View Full Team